scholarly journals Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model

2013 ◽  
Vol 6 (5) ◽  
pp. 523-532 ◽  
Author(s):  
Vasim Farooq ◽  
Patrick W. Serruys ◽  
Jung Ho Heo ◽  
Bill D. Gogas ◽  
Yoshinobu Onuma ◽  
...  
Keyword(s):  
Optical Coherence Tomography ◽  
Coronary Artery ◽  
Optical Coherence ◽  
Porcine Coronary Artery ◽  
Vascular Scaffolds ◽  
Bioresorbable Vascular Scaffolds

scholarly journals Different vascular healing process between bioabsorbable polymer-coated everolimus-eluting stents versus bioresorbable vascular scaffolds via optical coherence tomography and coronary angioscopy (the ENHANCE study: ENdothelial Healing Assessment with Novel Coronary tEchnology)

2019 ◽  
Vol 35 (4) ◽  
pp. 463-473 ◽  
Author(s):  
Wan Azman Wan Ahmad ◽  
Takaharu Nakayoshi ◽  
Ahmad Syadi Mahmood Zuhdi ◽  
Muhammad Dzafir Ismail ◽  
Imran Zainal Abidin ◽  
...  
Keyword(s):  
Optical Coherence Tomography ◽  
Healing Process ◽  
Coronary Vessels ◽  
Optical Coherence ◽  
Bioabsorbable Polymer ◽  
Neointimal Thickness ◽  
Yellow Plaque ◽  
Coronary Angioscopy ◽  
Vascular Scaffolds ◽  
Bioresorbable Vascular Scaffolds

Abstract Recent clinical trials have raised concerns about the safety and efficacy of ABSORB™ bioresorbable vascular scaffolds (BVS). The difference in the vascular healing process between SYNERGY™ bioabsorbable polymer-coated everolimus-eluting stents (BP-EES) and BVS remains unclear. The aim of the ENHANCE study was to compare vascular healing on BP-EES versus BVS by optical coherence tomography (OCT) and coronary angioscopy (CAS) at 4- and 12-month follow-ups. This is a prospective, non-randomized, single center clinical trial. Thirteen eligible patients with multivessel disease were enrolled. BP-EES and BVS were simultaneously implanted in the same patients, but in different coronary vessels. Imaging follow-up with both OCT and CAS was completed in 11 patients at 12 months. Neointimal coverage rates were similar between the two groups based on OCT measurements. The neointimal thickness of BP-EES was significantly thicker at the 12th month than at the 4th month, whereas the neointimal thickness of BVS did not change between the measurements taken at the 4th and 12th month. Existence of intra-stent thrombus was significantly higher in the BVS group, compared to the BP-EES group. On the other hand, CAS revealed that red-thrombi and yellow-plaque were more frequently observed in BVS at 4 months and up to 12-month follow-ups than in BP-EES. These findings suggested that the evidence of instability remained up to 12 months in the vascular healing with BVS, compared to that with BP-EES. Vascular healing of the stented wall was recognized at the very early phase after BP-EES implantation. However, vascular healing with BVS was still incomplete after 12 months.

Sign in / Sign up

Export Citation Format

Share Document